AstraZeneca Hit Again With Antitrust Charges

Law360, New York (March 1, 2006, 12:00 AM EST) -- A government service cooperative has charged AstraZeneca with violating U.S. competition law, the latest swipe in a string of suits filed by nearly a dozen unions, pension funds and government agencies accusing the pharmaceutical giant of illegally trying to prevent generic versions of its blockbuster heart drug, Toprol-XL, from entering the marketplace.

The National Joint Powers Association, a self-funded cooperative which supplies goods and services to government agencies, says that Anglo-Swedish AstraZeneca’s illegal monopolization and attempt to monopolize the market for Toprol-XL and its generic versions...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.